中医药治疗围绝经期综合征代谢组学研究进展

doi:10.3760/cma.j.cn441417-20250326-17005

国际医药卫生导报 ›› 2025, Vol. 31 ›› Issue (17): 2843-2846.DOI: 10.3760/cma.j.cn441417-20250326-17005

中医药治疗围绝经期综合征代谢组学研究进展

王敏¹ 庄克川¹ 徐庆田¹ 王稳²

收稿日期:2025-03-26 出版日期:2025-09-01 发布日期:2025-09-25
通讯作者: 王稳，Email：wenwenpeking@126.com
基金资助:
山东省自然科学基金（ZR2023MH380）；山东省中医药科技项目（Q-2023089）；枣庄英才集聚工程专项

Research progress on metabolomics of traditional Chinese medicine in the treatment of perimenopausal syndrome

Wang Min¹, Zhuang Kechuan¹, Xu Qingtian¹, Wang Wen²

Received:2025-03-26 Online:2025-09-01 Published:2025-09-25
Contact: Wang Wen, Email: wenwenpeking@126.com
Supported by:
Shandong Provincial Natural Science Foundation (ZR2023MH380); Shandong Provincial Project for Traditional Chinese Medicine Science and Technology (Q-2023089); Special Fund for Zaozhuang Talent Aggregation Project

摘要/Abstract

摘要： 围绝经期综合征是女性进入围绝经期阶段，因体内雌激素水平下降出现的以月经紊乱、潮热盗汗、失眠、情绪波动等一系列症状为主的疾病，直接影响其身心健康和生活质量。中医药治疗围绝经期综合征效果显著，其机制涉及调节机体内代谢相关的生物标志物及其相关代谢通路。本文通过阐述近些年中医疗法对围绝经期综合征代谢调节方面的影响，为该疾病治疗的作用机制提供更多依据。

关键词:

围绝经期综合征, 代谢组学, 中医药, 进展

Abstract: Perimenopausal syndrome is a disease that occurs when women enter the perimenopausal stage and experience a decline in estrogen levels. It is characterized by a series of symptoms such as irregular menstruation, hot flashes and night sweats, insomnia, and mood swings, which directly affect their physical and mental health and quality of life. Traditional Chinese medicine has a remarkable therapeutic effect on perimenopausal syndrome. The mechanism involves regulating the biological markers related to metabolism within the body and the corresponding metabolic pathways. This article elaborates on the impact of traditional Chinese medicine therapies on the metabolic regulation of perimenopausal syndrome in recent years, providing more evidence for the mechanism of action in the treatment of this disease.

Key words:

Perimenopausal syndrome, Metabolomics, Traditional Chinese medicine, Progress

王敏庄克川徐庆田王稳.

中医药治疗围绝经期综合征代谢组学研究进展 [J]. 国际医药卫生导报, 2025, 31(17): 2843-2846.

Wang Min, Zhuang Kechuan, Xu Qingtian, Wang Wen.

Research progress on metabolomics of traditional Chinese medicine in the treatment of perimenopausal syndrome [J]. International Medicine and Health Guidance News, 2025, 31(17): 2843-2846.

参考文献

[1] 郁琦,崔小娟.绝经激素治疗临床应用争议及展望[J].中国计划生育和妇产科,2022,14(1):3-6,28. DOI:10.3969/j.issn.1674-4020.2022.01.01.
[2] 李冀,潘明月,李想,等.中医药治疗围绝经期综合征研究进展[J].辽宁中医药大学学报,2021,23(9):1-5.DOI:10.13194/j.issn.1673-842x.2021.09.001.
[3] 谢幸,苟文丽.妇产科学[M].9版.北京:人民卫生出版社,2018:353-356.
[4] 中华医学会妇产科学分会绝经学组.中国绝经管理与绝经激素治疗指南(2018)[J].协和医学杂志,2018,9(6):512-525.DOI:10.3969/j.issn.1674-9081.2018.06.007.
[5] 郝海平.我国代谢调控与药物靶标发现研究的进展与展望[J].中国临床药理学与治疗学,2021,26(8):955-963. DOI:10.12092/j.issn.1009-2501.2021.08.009.
[6] Nicholson JK, Lindon JC. Systems biology: metabonomics[J]. Nature, 2008,455(7216):1054-1056. DOI: 10.1038/4551054a.
[7] Forges T, Monnier-Barbarino P, Faure GC, et al. Autoimmunity and antigenic targets in ovarian pathology[J]. Hum Reprod Update, 2004,10(2):163-175. DOI: 10.1093/humupd/dmh014.
[8] Wang X, Sun H, Zhang A, et al. Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine[J]. J Pharm Biomed Anal, 2011,55(5):859-868. DOI: 10.1016/j.jpba.2011.01.042.
[9] 杜彩凤,毛宇楠,高嘉,等.基于1H-NMR代谢组学的绝经期综合征血清代谢标志物研究[J].中国临床药理学与治疗学,2023,28(9):961-968. DOI:10.12092/j.issn.1009-2501.2023.09.001.
[10] 王燕,翟琪,佟玉静. 不同证型更年期综合征妇女血浆UPLC-QTOF/MS代谢组学特征研究[J]. 现代中西医结合杂志,2017,26(26):2874-2877,2881. DOI:10.3969/j.issn.1008-8849.2017.26.008.
[11] Stensen MH, Tanbo T, Storeng R, et al. Advanced glycation end products and their receptor contribute to ovarian ageing[J]. Hum Reprod, 2014,29(1):125-134. DOI: 10.1093/humrep/det419.
[12] Cataldi T, Cordeiro FB, Costa Ldo V, et al. Lipid profiling of follicular fluid from women undergoing IVF: young poor ovarian responders versus normal responders[J]. Hum Fertil (Camb), 2013, 16(4):269-277. DOI: 10.3109/14647273.2013.852255.
[13] Pacella L, Zander-Fox DL, Armstrong DT, et al. Women with reduced ovarian reserve or advanced maternal age have an altered follicular environment[J]. Fertil Steril, 2012, 98(4):986-994. e1-e2. DOI: 10.1016/j.fertnstert.2012.06.025.
[14] Li LL, Yang Y, Ma CM, et al. Effects of soybean isoflavone aglycone on osteoporosis in ovariectomized rats[J]. Front Nutr, 2023, 10:1122045. DOI: 10.3389/fnut.2023.1122045.
[15] 曹卫红,彭经纬,梁新国.激素替代疗法治疗围绝经期综合征的进展[J].海南医学,2013,24(24):3679-3681.DOI:10.3969/j.issn.1003-6350.2013.24.1524.
[16] 蔡熙,黄晖,王岚. 围绝经期动物模型的研究进展[J]. 中国实验方剂学杂志,2007,13(10):71-封3. DOI:10.3969/j.issn.1005-9903.2007.10.023.
[17] Chang D, Weljie A, Newton J. Leveraging latent information in NMR spectra for robust predictive models[J]. Pac Symp Biocomput, 2007:115-126.
[18] 李孟莹.整合网络药理与代谢组学研究丹栀逍遥方抗围绝经期抑郁的作用机制[D].北京:中国中医科学院,2024.DOI:10.27658/d.cnki.gzzyy.2024.000379.
[19] Lebowitz JJ, Kissiwaa SA, Engeln KA, et al. Synaptotagmin-7 counteracts short-term depression during phasic dopamine release[J]. eNeuro, 2024,11(3):ENEURO.0501-23.2024. DOI: 10.1523/ENEURO.0501-23.2024.
[20] 杨婧雯,王英,巩子汉,等.逍遥散对脂多糖诱导抑郁样小鼠细胞凋亡的作用机制[J].中国实验方剂学杂志,2024,30(16):36-43.DOI:10.13422/j.cnki.syfjx.20240416.
[21] Xie Z, Huang J, Sun G, et al. Integrated multi-omics analysis reveals gut microbiota dysbiosis and systemic disturbance in major depressive disorder[J]. Psychiatry Res, 2024,334:115804. DOI: 10.1016/j.psychres.2024.115804.
[22] Kaalund SS, Newburn EN, Ye T, et al. Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain[J]. Mol Psychiatry, 2014, 19(12):1258-1266. DOI: 10.1038/mp.2013.165.
[23] Corrales E, Navarro A, Cuenca P, et al.Candidate gene study reveals DRD1 and DRD2 as putative interacting risk factors for youth depression[J]. Psychiatry Res, 2016,244:71-77. DOI: 10.1016/j.psychres.2016.07.032.
[24] 廉婷,安书成.海马微量注射神经肽Y通过抑制一氧化氮合酶改善大鼠抑郁样行为[J].生理学报,2010,62(3):237-246.DOI:10.13294/j.aps.2010.03.009.
[25] 杨莹,胡晶,李培,等.基于非靶向代谢组学探讨二至丸改善去卵巢小鼠心肌损伤的多靶点作用[J].中国实验方剂学杂志,2025,31(1):74-84.DOI:10.13422/j.cnki.syfjx.20241265.
[26] Chen H, Wang Z, Qin M, et al. Comprehensive metabolomics identified the prominent role of glycerophospholipid metabolism in coronary artery disease progression[J]. Front Mol Biosci, 2021, 8:632950. DOI: 10.3389/fmolb.2021.632950.
[27] 李静,郭志华,刘建和,等.基于代谢组学探讨血府逐瘀汤对冠心病心血瘀阻证模型大鼠的疗效机制[J].中国中药杂志,2023,48(20):5623-5631.DOI:10.19540/j.cnki.cjcmm.20230710.702.
[28] 生宁,王彩虹,贾志鑫,等.代谢组学探索复方二仙汤调节双侧去卵巢大鼠脂代谢紊乱特征[J].药学学报,2021,56(9):2403-2409.DOI:10.16438/j.0513-4870.2021-0649.
[29] 刘丽玮.基于代谢组学的金匮肾气丸对16月龄小鼠增龄性改变的影响研究[D]. 哈尔滨:黑龙江中医药大学,2018.
[30] Cipriani C, Pepe J, Bertoldo F, et al. The epidemiology of osteoporosis in Italian postmenopausal women according to the National Bone Health Alliance (NBHA) diagnostic criteria: a multicenter cohort study[J]. J Endocrinol Invest, 2018, 41(4):431-438. DOI: 10.1007/s40618-017-0761-4.
[31] 郭强.基于非靶向代谢组学探讨龟鹿二仙胶预防绝经后骨质疏松症的机制[D].沈阳:辽宁中医药大学,2023.DOI:10.27213/d.cnki.glnzc.2023.000650.
[32] Tan J, McKenzie C, Potamitis M, et al. The role of short-chain fatty acids in health and disease[J]. Adv Immunol, 2014, 121:91-119.DOI:10.1016/B978-0-12-800100-4.00003-9.
[33] Zhang L, Wang Y, Xu Y, et al. Metabonomic analysis reveals efficient ameliorating effects of acupoint stimulations on the menopause-caused alterations in mammalian metabolism[J]. Sci Rep, 2014, 4:3641. DOI: 10.1038/srep03641.
[34] Chen GZ, Xu YX, Zhang JW, et al. Effect of acupoint catgut-embedding on the quality of life, reproductive endocrine and bone metabolism of postmenopausal women[J]. Chin J Integr Med, 2010, 16(6):498-503. DOI: 10.1007/s11655-010-0574-1.

中医药治疗围绝经期综合征代谢组学研究进展

Research progress on metabolomics of traditional Chinese medicine in the treatment of perimenopausal syndrome

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	赵洲刘为朋李宗睿王睿智胡宝光. 高血压大鼠模型的研究现状 [J]. 国际医药卫生导报, 2025, 31(9): 1465-1470.
[2]	昝兴淳. 通督调神针刺治疗脑卒中后吞咽障碍的研究进展与展望 [J]. 国际医药卫生导报, 2025, 31(9): 1470-1474.
[3]	李强. 超声引导下射频消融治疗甲状腺微小乳头状癌的研究进展 [J]. 国际医药卫生导报, 2025, 31(8): 1258-1260.
[4]	洪金全黄震宇黄惠炆黄豪博. 胸苷酸合成酶基因在肿瘤发生发展中的研究进展 [J]. 国际医药卫生导报, 2025, 31(8): 1260-1265.
[5]	蒋萌赵静如刘惠刘庆新. 自噬与缺血性脑血管疾病的研究进展 [J]. 国际医药卫生导报, 2025, 31(8): 1265-1269.
[6]	刘汉清孙银萍赵强任帅. MSI-H/dMMR亚组局部晚期结直肠癌患者新辅助免疫治疗研究进展 [J]. 国际医药卫生导报, 2025, 31(8): 1270-1274.
[7]	李彤. 新质生产力背景下中医药成果价值再挖掘的法律协同保障策略 [J]. 国际医药卫生导报, 2025, 31(7): 1126-1129.
[8]	朱鹏唐文玲覃刚. 结直肠癌中微小RNA功能及临床价值进展 [J]. 国际医药卫生导报, 2025, 31(6): 886-890.
[9]	潘文昕姜伟炜. 结肠镜检查时机对缺血性结肠炎患者预后影响的研究进展 [J]. 国际医药卫生导报, 2025, 31(6): 914-917.
[10]	张子怡孙大康. TRIM22抗HIV-1作用机制研究进展 [J]. 国际医药卫生导报, 2025, 31(6): 918-922.
[11]	易伟米倩倩赵洁李博宇王丹. 彩色多普勒血流成像在球后血流动力学检测中的应用 [J]. 国际医药卫生导报, 2025, 31(6): 922-926.
[12]	陈秀珠张凯韦岩笑丛晨阳. 甲状腺相关眼病的药物治疗研究进展 [J]. 国际医药卫生导报, 2025, 31(6): 927-929.
[13]	李晓童于胜强. 肾小管细胞来源外泌体在肾纤维化中的研究进展 [J]. 国际医药卫生导报, 2025, 31(5): 712-718.
[14]	张涵孙婷王延飞张肖林车娟. 移植后淋巴组织增生性疾病在儿童扁桃体腺样体肥大中的研究进展 [J]. 国际医药卫生导报, 2025, 31(5): 752-757.
[15]	莫家婵范万峰姜兴岳. 基于磁共振成像的影像组学在垂体腺瘤中的应用现状及进展 [J]. 国际医药卫生导报, 2025, 31(5): 757-760.